Showing 1 - 8 results of 8 for search 'Jasmin Barman‐Aksözen', query time: 0.06s Refine Results
  1. 1
    Are payors ready for transparent prices yet?

    Are payors ready for transparent prices yet? by Jasmin Barman-Aksözen

    Published 2022-08-01
    Get full text
    Article
  2. 2
    Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria

    Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria by Jasmin Barman-Aksözen

    Published 2019-08-01
    Get full text
    Article
  3. 3
    Current trials in erythropoietic protoporphyria: are placebo controls ethical?

    Current trials in erythropoietic protoporphyria: are placebo controls ethical? by Jasmin Barman-Aksözen, Mattia Andreoletti, Alessandro Blasimme

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study

    Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study by Jasmin Barman-Aksözen, Michèle Nydegger, Xiaoye Schneider-Yin, Anna-Elisabeth Minder

    Published 2020-08-01
    Get full text
    Article
  5. 5
    Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients

    Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients by Francesca Granata, Valentina Brancaleoni, Jasmin Barman-Aksözen, Margherita Scopetti, Giacomo De Luca, Silvia Fustinoni, Irene Motta, Irene Motta, Elena Di Pierro, Giovanna Graziadei

    Published 2022-07-01
    Get full text
    Article
  6. 6
    Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice

    Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice by Jasmin Barman-Aksözen, Paulina C´wiek, Vijay B. Bansode, Frank Koentgen, Judith Trüb, Pawel Pelczar, Paolo Cinelli, Xiaoye Schneider-Yin, Daniel Schümperli, Elisabeth I. Minder

    Published 2017-03-01
    Get full text
    Article
  7. 7
    First Report of a Low-Frequency Mosaic Mutation in the Hydroxymethylbilane Synthase Gene Causing Acute Intermittent Porphyria

    First Report of a Low-Frequency Mosaic Mutation in the Hydroxymethylbilane Synthase Gene Causing Acute Intermittent Porphyria by Adrian Belosevic, Anna-Elisabeth Minder, Morgan Gueuning, Franziska van Breemen, Gian Andri Thun, Maja P. Mattle-Greminger, Stefan Meyer, Alessandra Baumer, Elisabeth I. Minder, Xiaoye Schneider-Yin, Jasmin Barman-Aksözen

    Published 2023-09-01
    Get full text
    Article
  8. 8
    Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study

    Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER)... by Amy Dickey, Kristen Wheeden, Desiree Lyon, Sue Burrell, Sean Hegarty, Rocco Falchetto, Edrin R. Williams, Jasmin Barman‐Aksözen, Marc DeCongelio, Alison Bulkley, Joana E. Matos, Tarek Mnif, Jordanna Mora, John J. Ko, Stephen Meninger, Stephen Lombardelli, Danielle Nance

    Published 2023-01-01
    Get full text
    Article

Search Tools: